Yesterday | Reuters
J&J recalling certain lots of drugs after theft
“A voluntary withdrawal of products with lot numbers corresponding to that of the stolen product minimizes the possibility of inadvertent use of stolen product by physicians and, therefore, the overall risk to patients”
Johnson & Johnson said on Thursday it was voluntarily recalling specific lots of three of its medicines to protect patients from receiving potentially mishandled or damaged products after a truck carrying the ... via Reuters
Wednesday | Groong Armenian News Network
The Gazette , Canada May 11 2008 A glittering gala JENNIFER CAMPBELL, The Gazette [parts omitted] Jazzy J&J: Guess what, noties? The inaugural Joie de Vivre Gala fundraiser also worked the Jeans and Jools theme ... via Groong Armenian News Network
Monday May 12 | MediLexicon
Hearing To Focus On Direct-To-Consumer Ads For Prescription Drugs
“DTC ads do promote a pill culture in this country. They foster a culture in which we think there is a pill for every ill”
Officials for Pfizer , Johnson & Johnson , Merck and Schering-Plough on Thursday will testify at a House Energy and Commerce Oversight and Investigations Subcommittee hearing that Democrats hope will "lay the ... via MediLexicon
Saturday May 10 | Bizjournals
Boston Scientific wins Canadian court dismissal of J&J suit
Mass High Tech: The Journal of New England Technology - Mass High Tech A Canadian court has dismissed a lawsuit from Johnson & Johnson against Boston Scientific Corp. via Bizjournals
Thursday May 8 | Reuters
Group wants FDA to pull J&J birth control patch
“If Ortho-Evra had been designed as a pill, it is unlikely to have been approved because of its increased estrogen content”
A U.S. advocacy group is urging the Food and Drug Administration to pull Johnson & Johnson's birth control patch from the market after studies found an increased risk of dangerous blood clots. via Reuters
Tuesday May 6 | IPBiz
Sunday May 4 | New York Daily News
P&G sues J&J over whitening strips
“Whenever you have growth in the category, that's a good thing, but there's more competitive activity.”
Procter & Gamble Co. said Friday it is suing rival Johnson & Johnson, alleging patent infringement over teeth-whitening strips. via New York Daily News
Wednesday Apr 30 | Home News Tribune
J&J cuts 400 sales jobs amid drug safety problems
Drug safety problems are being blamed. The New Brunswick, N.J.-based company is consolidating marketing and sales departments at its biotechnology businesses. via Home News Tribune
Tuesday Apr 29 | Seeking Alpha
Merit Medical: Resilient and Poised for Continued Growth
The healthcare equipment sector has a history of resilience. The sector remained strong during the economic downturn earlier this decade and appears to be holding its own now. via Seeking Alpha
Sunday Apr 27 | Adweek
NEW YORK Johnson & Johnson is shifting creative duties on its Lubriderm brand of skincare lotion to Roberts & Tarlow from BBDO, sources said. via Adweek







